The Dana-Farber Cancer Institute in Boston has announced a $25 million gift from Jonathan Lavine and his wife, Jeannie, in support of preventative cancer therapy research.
The gift will establish the Lavine Family Fund for Preventative Cancer Therapies and support research on precursor conditions, immunotherapies, and innovative approaches to early detection, as well as endow a cluster of three chairs to be known as the Lavine Family Chairs for Preventative Cancer Therapies.
The Lavines are longtime supporters of Dana-Farber, where Jonathan Lavine's mother was treated successfully for non-Hodgkin lymphoma more than two decades ago, and in 2013 made a gift of $10 million in support of an initiative aimed at enhancing the patient experience.
"Early detection and cancer prevention are essential to the fight against cancer. Effective early detection methods and therapies will enable doctors to save more lives," said Lavine, a co-managing partner at Bain Capital. "It is too common that cancer is not discovered and diagnosed until a patient is experiencing symptoms, at which point the cancer has progressed to a point where it is not easily treated. To defeat cancer, early detection and prevention research are absolutely critical."